基于中西药理比较的蒲黄生物活性成分分析

曲靖师范学院学报 ›› 2017, Vol. 36 ›› Issue (6): 37-40.

基于中西药理比较的蒲黄生物活性成分分析

施如枫,于瑞雪,白现广

平顶山学院医学院,河南平顶山 467000

收稿日期:2017-09-21 出版日期:2017-12-10
通讯作者: 白现广,平顶山学院医学院讲师,主要从事中药活性成分提取及药理分析研究.
基金资助:
平顶山学院2015年大学生科技创新基金项目“蒲黄生物活性成分分析及中医药理比较” (S＆TIF2016127).

Analysis of Bioactive Components of Pollen Typhae Based on Comparative Study on Pharmacological Effects of the Traditional Chinese Drug and the Western Drug

Shi Rufeng,Yu Ruixue,Bai Xianguang

School of Medicine, Pingdingshan University, Pingdingshan Henan, 476000,China

Received:2017-09-21 Published:2017-12-10

摘要/Abstract

摘要： 通过对中药蒲黄与西药菠萝蛋白酶药理的比较,分析认为蒲黄与菠萝蛋白酶药理作用基本相同,蒲黄中具有活血化瘀药效的生物活性成分是能被消化道完整吸收的具有纤维蛋白溶解活性的蛋白酶,同时指出了蒲黄药用中存在的问题、注意事项及未来的研究方向.

关键词: 蒲黄, 菠萝蛋白酶, 活性成分

Abstract: A comparison in pharmacological effects between the traditional Chinese drugs Pollen Typhae and the Western drug Bromelain shows that Pollen Typhae plays a very similar pharmacologic role to Bromelain. It is found that Pollen Typhae contains the blood-activating and stasis-dissolving components, which are the fibrinolytic enzyme that can be absorbed into blood from the gastrointestinal tract. Furthermore, the problems, the precautions and the possible research directions of Pollen Typhae’s application in medicine are put forward.

Key words: Pollen Typhae, Bromelain, bioactive components

中图分类号:

R931.6

施如枫,于瑞雪,白现广. 基于中西药理比较的蒲黄生物活性成分分析[J]. 曲靖师范学院学报, 2017, 36(6): 37-40.

Shi Rufeng,Yu Ruixue,Bai Xianguang. Analysis of Bioactive Components of Pollen Typhae Based on Comparative Study on Pharmacological Effects of the Traditional Chinese Drug and the Western Drug[J]. JOURNAL OF QUJING NORMAL UNIVERSITY, 2017, 36(6): 37-40.

参考文献

[1] 国家药典委员会.中华人民共和国药典(一部)[M]. 北京:中国医药科技出版社,2015:353.
[2] 董瑞兰.菠萝蛋白酶的分离纯化及部分应用性质的研究[D]. 福州:福建农林大学,2010.
[3] 汪光远,周艳芬,何叶瑄,等.中草药蒲黄和桃仁的纤溶酶分离与纯化[D]. 保定:河北农业大学,2007.
[4] 李景辉,陈才法,李雯雯,等.蒲黄药理活性及临床应用[J]. 安徽农业科学,2011,39(16):9604-9606.
[5] 刘新锐,刘宝庆.莲藕蒲黄汤治疗慢性肾炎尿血44例[J]. 吉林中医药,2006,26(8):25.
[6] 柳琳,李善成,张相宜,等.复方蒲黄提取物对肾炎性血尿大鼠模型的影响[J]. 中国药学杂志,2013,48(22):1919-1922.
[7] 王海波,王章元.蒲黄药理作用的研究进展[J]. 医药导报,2015,24(4):318-319.
[8] 梁晶晶.水烛香蒲花粉(蒲黄)防治心肌缺血活性物质基础及其新资源的开发研究[D]. 上海:第二军医大学,2006.
[9] Ley C M, Tsiami A, Ni Q ,et al. A Review of the Use of Bromelain in Cardiovascular Diseases[J]. Journal of Integrative Medicine,2011,9(7):702-710.
[10] Park W H, Shin S S, Lee Y C, et al. The Inhibitory Effects of Silso-San -Gami on Atherosclerosis in KHC Rabbits[J]. Thromb Res, 2004,113( 3-4) : 235-241.
[11] 王丹,孙刚,王瑶. 蒲黄总黄酮含药血清对巨噬细胞自体吞噬及Akt/mTOR信号通路的影响[J].实用医学杂志,2017,33(16):2653-2657.
[12] 王丽君,廖矛川,肖培根.中药蒲黄的化学与药理活性[J]. 时珍国医国药,1998,9(1):49-50.
[13] 陈才法,缪进,李景辉,等. 蒲黄水提物对小鼠Lewis肺癌的抑制作用[J]. 解放军药学学报,2008,24(3):192-195.
[14] 郭骏骐,李伟民,范成香,等.蒲黄提取物对PSD大鼠血清白细胞介素6和肿瘤坏死因子α的影响[DB/CD].北京:中国学术期刊(光盘版)》电子杂志社有限公司,2013.
[15] Mynott T L, Luke R K, Chandler D S. Oral Administration of Protease Inhibits Enterotoxigenic Escherichia Coli Receptor Activity in Piglet Small Intestine[J]. Gut,1996,38(1):28-32.
[16] 张水寒.复方蒲黄缓释片的制剂学研究[D]. 北京:中国中医研究院中药研究所,2014.
[17] 李军东,李建兰,刘永.炮制蒲黄炭过敏1例[J]. 时珍国药研究,1997,8(1):86.
[18] Hale L P, Chichlowski M, Trinh C T, et al.Dietary Supplementation with Fresh Pineapple Juice Decreases inFlammation and Colonic Neoplasia in IL-10-Deficient Mice with Colitis[J]. Inflammatory Bowel Diseases,2010,16(12):2012-2021.
[19] 冯晓桃,王文健.蒲黄治疗糖尿病的药理机制研究进展[J]. 上海中医药杂志,2013,47(4):94-96.
[20] 孔祥鹏,陈佩东,张丽,等.蒲黄与蒲黄炭对血瘀大鼠血液流变性及凝血时间的影响[J]. 中国实验方剂学杂志,2011,17(6):129-132.
[21] 任文华,黄桂秋,徐德敏,等.蒲黄、蒲黄制剂对高胆固醇血症和巨噬细胞功能影响的研究[J]. 上海中医药杂志,1989(8):46-48.
[22] 张彩英,徐德敏,傅叔彦,等.蒲黄对实验性动脉粥样硬化和食饵性高胆固醇血症的影响[J]. 上海第二医学院学报,1983(4):51-53.